--> ZTS -0,77%
Co hosted its first-ever Investor Day, discussing with investors and analysts the company's leadership position in the animal health industry and the strategy and initiatives underway that will drive growth and create value for shareholders. The company also provided full-year 2015 financial guidance and outlined its longer term financial goals through 2017.
CFO Paul Herendeen indicated the company could grow revenue in the range of 5% to 7% on an operational basis for 2016 and 2017, and grow adjusted net income in the range of 11% to 16% on an operational basis for 2016 and 2017.
For full-year 2015, the company offered the following financial guidance:
Revenue of between $4.850 billion to $4.950 billion (6.5% to 8.5% growth on an operational basis; vs $4.96 bln Capital IQ Consensus Estimate)
Adjusted diluted EPS1 for the full year between $1.61 to $1.68 per share (vs $1.71 Capital IQ Consensus Estimate)